(Q35217998)

7 August 2017

0 references

1 reference

title

Modern management of locally advanced cervical carcinoma (English)

1 reference

7 August 2017

Alfonso Dueñas-Gonzalez

1

1 reference

7 August 2017

Lucely Cetina

2

1 reference

7 August 2017

Ignacio Mariscal

3

1 reference

7 August 2017

Jaime de la Garza

4

1 reference

7 August 2017

1 October 2003

1 reference

7 August 2017

Cancer Treatment Reviews

1 reference

7 August 2017

29

1 reference

7 August 2017

5

1 reference

7 August 2017

389-399

1 reference

Estimating the world cancer burden: Globocan 2000.

7 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900068-9

7 January 2021

A follow-up study of patients with cervical dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900068-9

7 January 2021

Does screening by "Pap" smears help prevent cervical cancer? A case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900068-9

7 January 2021

Asian-american variants of human papillomavirus type 16 have extensive mutations in the E2 gene and are highly amplified in cervical carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900068-9

7 January 2021

Cancer statistics, 2001

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900068-9

7 January 2021

Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900068-9

7 January 2021

Hydroxyurea or placebo combined with radiation to treat stages iiib and iv cervical cancer confined to the pelvis

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900068-9

7 January 2021

Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900068-9

7 January 2021

Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group stud

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900068-9

7 January 2021

Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900068-9

7 January 2021

Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900068-9

7 January 2021

Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900068-9

7 January 2021

Chemoradiation and adjuvant chemotherapy in cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900068-9

7 January 2021

Interim results of a randomized trial of mitomycin C as an adjunct to radical radiotherapy in the treatment of locally advanced squamous-cell carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900068-9

7 January 2021

Chemoradiation for locally advanced cervical cancer: does it help?

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900068-9

7 January 2021

Randomized trial of epirubicin and cisplatin chemotherapy followed by pelvic radiation in locally advanced cervical cancer. Cervical Cancer Study Group of the Asian Oceanian Clinical Oncology Association

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900068-9

7 January 2021

A randomized trial of chemotherapy followed by pelvic radiation therapy in stage IIIB carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900068-9

7 January 2021

Chemotherapy Followed by Radiotherapy versus Radiotherapy Alone in Locally Advanced Cervical Cancer: A Randomized Study

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900068-9

7 January 2021

A randomized trial comparing platinum-based chemotherapy followed by radiotherapy vs. radiotherapy alone in patients with locally advanced cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900068-9

7 January 2021

Radiotherapy and neoadjuvant chemotherapy for cervical carcinoma. A randomized multicenter study of sequential cisplatin and 5-fluorouracil and radiotherapy in advanced cervical carcinoma stage 3B and 4A

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900068-9

7 January 2021

Induction chemotherapy and radiotherapy of advanced cancer of the cervix: a pilot study and phase III randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900068-9

7 January 2021

A randomised, prospective, phase III clinical trial of primary bleomycin, ifosfamide and cisplatin (BIP) chemotherapy followed by radiotherapy versus radiotherapy alone in inoperable cancer of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900068-9

7 January 2021

The role of neoadjuvant intraarterial infusion chemotherapy with cisplatin and bleomycin for locally advanced cervical cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900068-9

7 January 2021

Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900068-9

7 January 2021

Randomized Trial of Neoadjuvant Cisplatin, Vincristine, Bleomycin, and Radical Hysterectomy Versus Radiation Therapy for Bulky Stage IB and IIA Cervical Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900068-9

7 January 2021

Sequential induction chemotherapy and concomitant chemoradiotherapy in the management of locoregionally advanced laryngeal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900068-9

7 January 2021

Induction chemotherapy followed by concomitant chemoradiotherapy for non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900068-9

7 January 2021

A phase II study of gemcitabine and cisplatin combination as induction chemotherapy for untreated locally advanced cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900068-9

7 January 2021

The advantages of concurrent chemoradiation after neoadjuvant chemotherapy for locally advanced cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900068-9

7 January 2021

Neoadjuvant chemotherapy with cisplatin, ifosfamide and paclitaxel for locally advanced squamous-cell cervical cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900068-9

7 January 2021

Combination therapy with irinotecan and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900068-9

7 January 2021

Phase II study of cisplatin and vinorelbine as first-line chemotherapy in patients with carcinoma of the uterine cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900068-9

7 January 2021

Concomitant chemoradiation versus neoadjuvant chemotherapy in locally advanced cervical carcinoma: results from two consecutive phase II studies

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900068-9

7 January 2021

Neoadjuvant chemotherapy followed by surgery in locally advanced cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900068-9

7 January 2021

Radical surgery following neoadjuvant chemotherapy for patients with stage IIIB cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900068-9

7 January 2021

Neoadjuvant intraarterial chemotherapy followed by radical hysterectomy and/or radiotherapy for locally advanced cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900068-9

7 January 2021

Type III radical hysterectomy after induction chemotherapy for patients with locally advanced cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900068-9

7 January 2021

Neoadjuvant chemotherapy in locally advanced carcinoma of the cervix uteri

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900068-9

7 January 2021

Induction chemotherapy followed by concurrent chemoradiation for advanced head and neck cancer: improved disease control and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900068-9

7 January 2021

Induction chemotherapy followed by concomitant chemoradiation for cervical esophageal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900068-9

7 January 2021

Induction chemotherapy with gemcitabine and oxaliplatin for locally advanced cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900068-9

7 January 2021

Phase I study of topotecan and radiation therapy in advanced cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900068-9

7 January 2021

Gemcitabine activity in cervical cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900068-9

7 January 2021

[The intensification of the radiotherapeutic effect on HeLa cells by gemcitabine]

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900068-9

7 January 2021

A phase II study of gemcitabine and cisplatin in patients with advanced, persistent, or recurrent squamous cell carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900068-9

7 January 2021

Weekly cisplatin/low-dose gemcitabine combination for advanced and recurrent cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900068-9

7 January 2021

Phase II study of concurrent gemcitabine and radiotherapy in locally advanced stage IIIB cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900068-9

7 January 2021

Preoperative chemoradiation treatment strategies for localized sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900068-9

7 January 2021

T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900068-9

7 January 2021

High dose radiation therapy and chemotherapy as induction treatment for stage III nonsmall cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900068-9

7 January 2021

Concomitant chemoradiation prior to surgery in the treatment of advanced cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900068-9

7 January 2021

Pilot study of concurrent cisplatin, 5-fluorouracil, and external beam radiotherapy prior to radical surgery +/- intraoperative electron beam radiotherapy in locally advanced cervical cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900068-9

7 January 2021

Phase I-II trial of preoperative chemoradiation in locally advanced cervical carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2803%2900068-9

7 January 2021

10.1016/S0305-7372(03)00068-9

Identifiers

DOI

1 reference

7 August 2017

1 reference